Organoid

Last updated

Intestinal organoid grown from Lgr5+ stem cells Intestinal organoid.PNG
Intestinal organoid grown from Lgr5+ stem cells

An organoid is a miniaturised and simplified version of an organ produced in vitro in three dimensions that mimics the key functional, structural, and biological complexity of that organ. [1] It is derived from one or a few cells from a tissue, embryonic stem cells, or induced pluripotent stem cells, which can self-organize in three-dimensional culture owing to their self-renewal and differentiation capacities. The technique for growing organoids has rapidly improved since the early 2010s, and The Scientist named it one of the biggest scientific advancements of 2013. [2] Scientists and engineers use organoids to study development and disease in the laboratory, for drug discovery and development in industry, [3] personalized diagnostics and medicine, gene and cell therapies, tissue engineering, and regenerative medicine.

Contents

History

Attempts to create organs in vitro started with one of the first dissociation-reaggregation experiments [4] where Henry Van Peters Wilson demonstrated that mechanically dissociated sponge cells can reaggregate and self-organize to generate a whole organism. [5] In the subsequent decades, multiple labs were able to generate different types of organs [4] in vitro through the dissociation and reaggregation of organ tissues obtained from amphibians [6] and embryonic chicks. [7] The formation of first tissue-like colonies in vitro was observed for the first time by co-culturing keratinocytes and 3T3 fibroblasts. [8] The phenomena of mechanically dissociated cells aggregating and reorganizing to reform the tissue they were obtained from subsequently led to the development of the differential adhesion hypothesis by Malcolm Steinberg. [4] With the advent of the field of stem cell biology, the potential of stem cells to form organs in vitro was realized early on with the observation that when stem cells form teratomas or embryoid bodies, the differentiated cells can organize into different structures resembling those found in multiple tissue types. [4] The advent of the field of organoids, started with a shift from culturing and differentiating stem cells in two dimensional (2D) media, to three dimensional (3D) media to allow for the development of the complex 3-dimensional structures of organs. [4] Utilization of 3D media culture media methods for the structural organization was made possible with the development of extracellular matrices (ECM). [9] In the late 1980s, Bissell and colleagues showed that a laminin rich gel can be used as a basement membrane for differentiation and morphogenesis in cell cultures of mammary epithelial cells. [10] [11] Since 1987, researchers have devised different methods for 3D culturing, and were able to utilize different types of stem cells to generate organoids resembling a multitude of organs. [4] In the 1990s, in addition to their role in physical support, the role of ECM components in gene expression by their interaction with integrin-based focal adhesion pathways was reported. [12] In 2006, Yaakov Nahmias and David Odde showed the self-assembly of vascular liver organoid maintained for over 50 days in vitro. [13] In 2008, Yoshiki Sasai and his team at RIKEN institute demonstrated that stem cells can be coaxed into balls of neural cells that self-organize into distinctive layers. [14] In 2009 the Laboratory of Hans Clevers at Hubrecht Institute and University Medical Center Utrecht, Netherlands, showed that single LGR5-expressing intestinal stem cells self-organize to crypt-villus structures in vitro without necessity of a mesenchymal niche, making them the first organoids. [15] In 2010, Mathieu Unbekandt & Jamie A. Davies demonstrated the production of renal organoids from murine fetus-derived renogenic stem cells. [16] In 2014, Qun Wang and co-workers engineered collagen-I and laminin based gels and synthetic foam biomaterials for the culture and delivery of intestinal organoids [17] and encapsulated DNA-functionalized gold nanoparticles into intestinal organoids to form an intestinal Trojan horse for drug delivery and gene therapy. [18] Subsequent reports showed significant physiological function of these organoids in vitro [19] and in vivo . [20] [21]

Other significant early advancements included in 2013, Madeline Lancaster at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences established a protocol starting from pluripotent stem cells to generate cerebral organoids that mimic the developing human brain's cellular organization. [22] Meritxell Huch and Craig Dorrell at Hubrecht Institute and University Medical Center Utrecht demonstrated that single Lgr5+ cells from damaged mouse liver can be clonally expanded as liver organoids in Rspo1-based culture medium over several months. [23] In 2014, Artem Shkumatov et al. at the University of Illinois at Urbana-Champaign demonstrated that cardiovascular organoids can be formed from ES cells through modulation of the substrate stiffness, to which they adhere. Physiological stiffness promoted three-dimensionality of EBs and cardiomyogenic differentiation. [24]

Properties

Lancaster and Knoblich [4] define an organoid as a collection of organ-specific cell types that develops from stem cells or organ progenitors, self-organizes through cell sorting and spatially restricted lineage commitment in a manner similar to in vivo, and exhibits the following properties:

Process

Organoid formation generally requires culturing the stem cells or progenitor cells in a 3D medium. [4] Stem cells have the ability to self-renew and differentiate into various cell subtypes, and they enable understanding the processes of development and disease progression. [25] Therefore organoids derived from stem cells enable studying biology and physiology at the organ level. [26] The 3D medium can be made using an extracellular matrix hydrogel such as Matrigel or Cultrex BME, which is a laminin-rich extracellular matrix that is secreted by the Engelbreth-Holm-Swarm tumor line. [27] Organoid bodies can then be made through embedding stem cells in the 3D medium. [4] When pluripotent stem cells are used for the creation of the organoid, the cells are usually, but not all the time, allowed to form embryoid bodies. [4] Those embryoid bodies are then pharmacologically treated with patterning factors to drive the formation of the desired organoid identity. [4] Organoids have also been created using adult stem cells extracted from the target organ, and cultured in 3D media. [28]

Biochemical cues have been incorporated in 3D organoid cultures and with exposure of morphogenes, morphogen inhibitors, or growth factors, organoid models can be developed using embryonic stem cells (ESCs) or adult stem cells (ASCs). Vascularization techniques can be utilized to embody microenvironments that are close to their counterparts, physiologically. Vasculature systems that can facilitate oxygen or nutrients to the inner mass of organoids can be achieved through microfluidic systems, vascular endothelial growth factor delivery systems, and endothelial cell-coated modules. [9] With patient-derived induced pluripotent stem cells (iPSCs) [29] and CRISPR/Cas-based genome editing [30] technologies, genome-edited or mutated pluripotent stem cells (PSCs) with altered signaling cues can be generated to control intrinsic cues within organoids.

Types

A multitude of organ structures have been recapitulated using organoids. [4] This section aims to outline the state of the field as of now through providing an abridged list of the organoids that have been successfully created, along with a brief outline based on the most recent literature for each organoid, and examples of how it has been utilized in research.

Cerebral organoid

A cerebral organoid describes artificially grown, in vitro , miniature organs resembling the brain. Cerebral organoids are created by culturing human pluripotent stem cells in a three-dimensional structure using rotational bioreactor and develop over the course of months. [22] The procedure has potential applications in the study of brain development, physiology and function. Cerebral organoids may experience "simple sensations" in response to external stimulation and neuroscientists are among those expressing concern that such organs could develop sentience. They propose that further evolution of the technique needs to be subject to a rigorous oversight procedure. [31] [32] [33] In 2023, researchers have built a hybrid biocomputer that combines laboratory-grown human brain organoids with conventional circuits, and can complete tasks such as voice recognition. [34] Cerebral Organoids are currently being used to research and develop Organoid Intelligence (OI) technologies. [35]

Gastrointestinal organoid

Gastrointestinal organoids refer to organoids that recapitulate structures of the gastrointestinal tract. The gastrointestinal tract arises from the endoderm, which during development forms a tube that can be divided in three distinct regions, which give rise to, along with other organs, the following sections of the gastrointestinal tract: [4]

  1. The foregut gives rise to the oral cavity and the stomach
  2. The midgut gives rise to the small intestines and the ascending colon
  3. The hindgut gives rise to the rectum and the rest of the colon

Organoids have been created for the following structures of the gastrointestinal tract:

Intestinal organoid

Intestinal organoids [15] have thus far been among the gut organoids generated directly from intestinal tissues or pluripotent stem cells. [4] One way human pluripotent stem cells can be driven to form intestinal organoids is through first the application of activin A to drive the cells into a mesoendodermal identity, followed by the pharmacological upregulation of Wnt3a and Fgf4 signaling pathways as they have been demonstrated to promote posterior gut fate. [4] Intestinal organoids have also been generated from intestinal stem cells, extracted from adult tissue and cultured in 3D media. [28] These adult stem cell-derived organoids are often referred to as enteroids or colonoids, depending on their segment of origin, and have been established from both the human and murine intestine. [15] [36] [37] Intestinal organoids consist of a single layer of polarized intestinal epithelial cells surrounding a central lumen. As such, recapitulate the crypt-villus structure of the intestine, by recapitulating its function, physiology and organization, and maintaining all the cell types found normally in the structure including intestinal stem cells. [4] Thus, intestinal organoids are a valuable model to study intestinal nutrient transport, [38] [39] drug absorption and delivery, [40] [41] nanomaterials and nanomedicine, [42] [43] incretin hormone secretion, [44] [45] and infection by various enteropathogens. [46] [47] For example, Qun Wang's team rationally designed artificial virus nanoparticles as oral drug delivery vehicles (ODDVs) with gut organoid-derived mucosal models [48] and demonstrated a new concept of using newly established colon organoids as tools for high-throughput drug screening, toxicity testing, and oral drug development. [49] Or recently, Sakib, S., and Zou, S. developed graphene oxide nanoparticles for delivering siRNA regulating expression of tumor necrosis factor-α, that aimed to treat intestinal organoids exhibiting an inflammatory phenotype. [50] Intestinal organoids also recapitulate the crypt-Villus structure to such a high degree of fidelity that they have been successfully transplanted to mouse intestines, and are hence highly regarded as a valuable model for research. [4] One of the fields of research that intestinal organoids have been utilized is that of stem cell niche. Intestinal organoids were used to study the nature of the intestinal stem cell niche, and research done with them demonstrated the positive role IL-22 has in maintaining in intestinal stem cells, [51] along with demonstrating the roles of other cell types like neurons and fibroblasts in maintenance of intestinal stem cells. [28] In the field of infection biology, different intestinal organoid-based model systems have been explored. On one hand, organoids can be infected in bulk by simply mixing them with the enteropathogen of interest. [52] However, to model infection via a more natural route starting from the intestinal lumen, microinjection of the pathogen is required. [53] [54] In addition, the polarity of intestinal organoids can be inverted, [55] and they can even be dissociated into single cells and cultured as 2D monolayers [56] [57] in order to make both the apical and basolateral sides of the epithelium more easily accessible. Intestinal organoids have also demonstrated therapeutic potential. [58]

An intestinal organoid (Minigut) grows up in 7 days. The scale bars are 200 mm. Intestinal Organoid.gif
An intestinal organoid (Minigut) grows up in 7 days. The scale bars are 200 μm.

In order to more accurately recapitulate the intestine in vivo, co-cultures of intestinal organoids and immune cells have been developed. [57] Furthermore, organ-on-a-chip models combine intestinal organoids with other cell types such as endothelial or immune cells as well as peristaltic flow. [59] [60]

Gastric organoid

Gastric organoids recapitulate at least partly the physiology of the stomach. Gastric organoids have been generated directly from pluripotent stem cells through the temporal manipulation of the FGF, WNT, BMP, retinoic acid and EGF signalling pathways in three-dimensional culture conditions. [61] Gastric organoids have also been generated using LGR5 expressing stomach adult stem cells. [62] Gastric organoids have been used as model for the study of cancer [63] [64] along with human disease [61] and development. [61] For example, one study [64] investigated the underlying genetic alterations behind a patient's metastatic tumor population, and identified that unlike the patient's primary tumor, the metastasis had both alleles of the TGFBR2 gene mutated. To further assess the role of TGFBR2 in the metastasis, the investigators created organoids where TGFBR2 expression is knocked down, through which they were able to demonstrate that reduced TGFBR2 activity leads to invasion and metastasis of cancerous tumors both in vitro and in vivo.

Lingual organoid

Lingual organoids are organoids that recapitulate, at least partly, aspects of the tongue physiology. Epithelial lingual organoids have been generated using BMI1 expressing epithelial stem cells in three-dimensional culture conditions through the manipulation of EGF, WNT, and TGF-β. [65] This organoid culture, however, lacks taste receptors, as these cells do not arise from Bmi1 expressing epithelial stem cells. [65] Lingual taste bud organoids containing taste cells, however, have been created using the LGR5+ or CD44+ stem/progenitor cells of circumvallate (CV) papilla tissue. [66] These taste bud organoids have been successfully created both directly from isolated Lgr5- or LGR6-expressing taste stem/progenitor cells. [67] and indirectly, through the isolation, digestion, and subsequent culturing of CV tissue containing Lgr5+ or CD44+ stem/progenitor cells. [66]

Other

Thymic organoids recapitulate at least partly the architecture and stem-cell niche functionality of the thymus, [71] which is a lymphoid organ where T cells mature. Thymic organoids have been generated through the seeding of thymic stromal cells in 3-dimensional culture. [71] Thymic organoids seem to successfully recapitulate the thymus' function, as co-culturing human hematopoietic or bone marrow stem cells with mouse thymic organoids resulted in the production of T-cells. [71]
Recent advances in cell repellent microtiter plates has allowed rapid, cost-effective screening of large small molecule drug like libraries against 3D models of pancreas cancer. These models are consistent in phenotype and expression profiles with those found in the lab of Dr. David Tuveson.

3D organoid models of brain cancer derived from either patient derived explants (PDX) or direct from cancer tissue is now easily achievable and affords high-throughput screening of these tumors against the current panel of approved drugs form around the world.

Self-assembled cell aggregates consisting of BMECs, astrocytes, and pericytes are emerging as a potential alternative to transwell and microfluidic models for certain applications. These organoides can generate many features of the BBB, such as the expression of tight junctions, molecular transporters, and drug efflux pumps, and can therefore be used to model drug transport across the BBB. Also, they can serve as a model for evaluating the interactions between the BBB and adjacent brain tissue and provide a platform for understanding the combined abilities of a new drug to overcome the BBB and its effect on brain tissue. In addition, such models are highly scalable and easier to manufacture and operate than microfluidic devices. However, they have limited ability to reconstruct the morphology and physiology of the BBB and are unable to simulate physiological flow and shear stress.

Basic research

Organoids enable to study how cells interact together in an organ, their interaction with their environment, how diseases affect them and the effect of drugs. In vitro culture makes this system easy to manipulate and facilitates their monitoring. While organs are difficult to culture because their size limits the penetration of nutrients, the small size of organoids limits this problem. On the other hand, they do not exhibit all organ features and interactions with other organs are not recapitulated in vitro. While research on stem cells and regulation of stemness was the first field of application of intestinal organoids, [15] they are now also used to study e.g. uptake of nutrients, drug transport and secretion of incretin hormones. [102] This is of great relevance in the context of malabsorption diseases as well as metabolic diseases such as obesity, insulin resistance, and diabetes.

Models of disease

Organoids provide an opportunity to create cellular models of human disease, which can be studied in the laboratory to better understand the causes of disease and identify possible treatments. The power of organoids in this regard was first shown for a genetic form of microcephaly, where patient cells were used to make cerebral organoids, which were smaller and showed abnormalities in early generation of neurons. [22] In another example, the genome editing system called CRISPR was applied to human pluripotent stem cells to introduce targeted mutations in genes relevant to two different kidney diseases, polycystic kidney disease and focal segmental glomerulosclerosis. [83] These CRISPR-modified pluripotent stem cells were subsequently grown into human kidney organoids, which exhibited disease-specific phenotypes. Kidney organoids from stem cells with polycystic kidney disease mutations formed large, translucent cyst structures from kidney tubules. When cultured in the absence of adherent cues (in suspension), these cysts reached sizes of 1 cm in diameter over several months. [103] Kidney organoids with mutations in a gene linked to focal segmental glomerulosclerosis developed junctional defects between podocytes, the filtering cells affected in that disease. [104] Importantly, these disease phenotypes were absent in control organoids of identical genetic background, but lacking the CRISPR mutations. [83] [103] [104] Comparison of these organoid phenotypes to diseased tissues from mice and humans suggested similarities to defects in early development. [103] [104]

As first developed by Takahashi and Yamanaka in 2007, induced pluripotent stem cells (iPSC) can also be reprogrammed from patient skin fibroblasts. [105] These stem cells carry the exact genetic background of the patient including any genetic mutations which might contribute to the development of human disease. Differentiation of these cells into kidney organoids has been performed from patients with Lowe Syndrome due to ORCL1 mutations. [106] This report compared kidney organoids differentiated from patient iPSC to unrelated control iPSC and demonstrated an inability of patient kidney cells to mobilise transcription factor SIX2 from the golgi complex. [106] Because SIX2 is a well characterised marker of nephron progenitor cells in the cap mesenchyme, the authors concluded that renal disease frequently seen in Lowe Syndrome (global failure of proximal tubule reabsorption or renal Fanconi syndrome) could be related to alteration in nephron patterning arising from nephron progenitor cells lacking this important SIX2 gene expression. [106]

Other studies have used CRISPR gene editing to correct the patient's mutation in the patient iPSC cells to create an isogenic control, which can be performed simultaneously with iPSC reprogramming. [107] [108] [109] Comparison of a patient iPSC derived organoid against an isogenic control is the current gold standard in the field as it permits isolation of the mutation of interest as the only variable within the experimental model. [110] In one such report, kidney organoids derived from iPSC of a patient with Mainzer-Saldino Syndrome due to compound heterozygous mutations in IFT140 were compared to an isogenic control organoid in which an IFT140 variant giving rise to a non-viable mRNA transcript was corrected by CRISPR. [108] Patient kidney organoids demonstrated abnormal ciliary morphology consistent with existing animal models which was rescued to wild type morphology in the gene corrected organoids. [108] Comparative transcriptional profiling of epithelial cells purified from patient and control organoids highlighted pathways involved in cell polarity, cell-cell junctions and dynein motor assembly, some of which had been implicated for other genotypes within the phenotypic family of renal ciliopathies. [108] Another report utilising an isogenic control demonstrated abnormal nephrin localisation in the glomeruli of kidney organoids generated from a patient with congenital nephrotic syndrome. [109]

Things such as epithelial metabolism can also be modelled. [111]

Personalised medicine

Intestinal organoids grown from rectal biopsies using culture protocols established by the Clevers group have been used to model cystic fibrosis, [112] and led to the first application of organoids for personalised treatment. [113] Cystic fibrosis is an inherited disease that is caused by gene mutations of the cystic fibrosis transmembrane conductance regulator gene that encodes an epithelial ion channel necessary for healthy epithelial surface fluids. Studies by the laboratory of Jeffrey Beekman (Wilhelmina Children's Hospital, University Medical Center Utrecht, The Netherlands) described in 2013 that stimulation of colorectal organoids with cAMP-raising agonists such as forskolin or cholera toxin induced rapid swelling of organoids in a fully CFTR dependent manner. [112] Whereas organoids from non-cystic fibrosis subjects swell in response to forskolin as a consequence of fluid transport into the organoids' lumens, this is severely reduced or absent in organoids derived from people with cystic fibrosis. Swelling could be restored by therapeutics that repair the CFTR protein (CFTR modulators), indicating that individual responses to CFTR modulating therapy could be quantitated in a preclinical laboratory setting. Schwank et al. also demonstrated that the intestinal cystic fibrosis organoid phenotype could be repaired by CRISPR-Cas9 gene editing in 2013. [114]

Follow-up studies by Dekkers et al. in 2016 revealed that quantitative differences in forskolin-induced swelling between intestinal organoids derived from people with cystic fibrosis associate with known diagnostic and prognostic markers such as CFTR gene mutations or in vivo biomarkers of CFTR function. [113] In addition, the authors demonstrated that CFTR modulator responses in intestinal organoids with specific CFTR mutations correlated with published clinical trial data of these treatments. This led to preclinical studies where organoids from patients with extremely rare CFTR mutations for who no treatment was registered were found to respond strongly to a clinically available CFTR modulator. The suggested clinical benefit of treatment for these subjects based on the preclinical organoid test was subsequently confirmed upon clinical introduction of treatment by members of the clinical CF center under supervision of Kors van der Ent (Department of Paediatric Pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, The Netherlands). These studies show for the first time that organoids can be used for the individual tailoring of therapy or personalised medicine.

Organoid transplants

The self-renewal and regenerative properties of intestinal organoids make them promising candidates for transplantation therapies, particularly for disease involving epithelial barrier disruption. Notably, transplantation of organoids into the duodenum of mice has been shown to aid in the recovery of mucosal damages on mice with ischemia-reperfusion injury. [115]

The first successful transplantation of an organoid into a human, a patient with ulcerative colitis whose cells were used for the organoid, was carried out in 2022. [116] [117]

As a model for developmental biology

Organoids offer researchers an exceptional model to study developmental biology. [118] Since the identification of pluripotent stem cells, there have been great advancements in directing pluripotent stem cells fate in vitro using 2D cultures. [118] These advancements in PSC fate direction, coupled with the advancements in 3D culturing techniques allowed for the creation of organoids that recapitulate the properties of various specific subregions of a multitude of organs. [118] The use of these organoids has thus greatly contributed to expanding our understanding of the processes of organogenesis, and the field of developmental biology. [118] In central nervous system development, for example, organoids have contributed to our understanding of the physical forces that underlie retinal cup formation. [118] [119] More recent work has extended cortical organoid growth periods extensively and at nearly a year under specific differentiation conditions, the organoids persist and have some features of human fetal development stages. [120]

See also

Related Research Articles

<span class="mw-page-title-main">Fibroblast</span> Animal connective tissue cell

A fibroblast is a type of biological cell typically with a spindle shape that synthesizes the extracellular matrix and collagen, produces the structural framework (stroma) for animal tissues, and plays a critical role in wound healing. Fibroblasts are the most common cells of connective tissue in animals.

<span class="mw-page-title-main">Gastrulation</span> Stage in embryonic development in which germ layers form

Gastrulation is the stage in the early embryonic development of most animals, during which the blastula, or in mammals the blastocyst, is reorganized into a two-layered or three-layered embryo known as the gastrula. Before gastrulation, the embryo is a continuous epithelial sheet of cells; by the end of gastrulation, the embryo has begun differentiation to establish distinct cell lineages, set up the basic axes of the body, and internalized one or more cell types including the prospective gut.

<span class="mw-page-title-main">Tissue engineering</span> Biomedical engineering discipline

Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, materials methods, and suitable biochemical and physicochemical factors to restore, maintain, improve, or replace different types of biological tissues. Tissue engineering often involves the use of cells placed on tissue scaffolds in the formation of new viable tissue for a medical purpose, but is not limited to applications involving cells and tissue scaffolds. While it was once categorized as a sub-field of biomaterials, having grown in scope and importance, it can be considered as a field of its own.

<span class="mw-page-title-main">Adult stem cell</span> Multipotent stem cell in the adult body

Adult stem cells are undifferentiated cells, found throughout the body after development, that multiply by cell division to replenish dying cells and regenerate damaged tissues. Also known as somatic stem cells, they can be found in juvenile, adult animals, and humans, unlike embryonic stem cells.

<span class="mw-page-title-main">Induced pluripotent stem cell</span> Pluripotent stem cell generated directly from a somatic cell

Induced pluripotent stem cells are a type of pluripotent stem cell that can be generated directly from a somatic cell. The iPSC technology was pioneered by Shinya Yamanaka and Kazutoshi Takahashi in Kyoto, Japan, who together showed in 2006 that the introduction of four specific genes, collectively known as Yamanaka factors, encoding transcription factors could convert somatic cells into pluripotent stem cells. Shinya Yamanaka was awarded the 2012 Nobel Prize along with Sir John Gurdon "for the discovery that mature cells can be reprogrammed to become pluripotent."

Renal stem cells are self-renewing, multipotent stem cells which are able to give rise to all the cell types of the kidney. It is involved in the homeostasis and repair of the kidney, and holds therapeutic potential for treatment of kidney failure.

An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture, integrated circuit (chip) that simulates the activities, mechanics and physiological response of an entire organ or an organ system. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context. By acting as a more sophisticated in vitro approximation of complex tissues than standard cell culture, they provide the potential as an alternative to animal models for drug development and toxin testing.

<span class="mw-page-title-main">Cerebral organoid</span> Artificial miniature brain like organ

A neural, or brain organoid, describes an artificially grown, in vitro, tissue resembling parts of the human brain. Neural organoids are created by culturing pluripotent stem cells into a three-dimensional culture that can be maintained for years. The brain is an extremely complex system of heterogeneous tissues and consists of a diverse array of neurons and glial cells. This complexity has made studying the brain and understanding how it works a difficult task in neuroscience, especially when it comes to neurodevelopmental and neurodegenerative diseases. The purpose of creating an in vitro neurological model is to study these diseases in a more defined setting. This 3D model is free of many potential in vivo limitations. The varying physiology between human and other mammalian models limits the scope of animal studies in neurological disorders. Neural organoids contain several types of nerve cells and have anatomical features that recapitulate regions of the nervous system. Some neural organoids are most similar to neurons of the cortex. In some cases, the retina, spinal cord, thalamus and hippocampus. Other neural organoids are unguided and contain a diversity of neural and non-neural cells. Stem cells have the potential to grow into many different types of tissues, and their fate is dependent on many factors. Below is an image showing some of the chemical factors that can lead stem cells to differentiate into various neural tissues; a more in-depth table of generating specific organoid identity has been published. Similar techniques are used on stem cells used to grow cerebral organoids.

Directed differentiation is a bioengineering methodology at the interface of stem cell biology, developmental biology and tissue engineering. It is essentially harnessing the potential of stem cells by constraining their differentiation in vitro toward a specific cell type or tissue of interest. Stem cells are by definition pluripotent, able to differentiate into several cell types such as neurons, cardiomyocytes, hepatocytes, etc. Efficient directed differentiation requires a detailed understanding of the lineage and cell fate decision, often provided by developmental biology.

Regeneration in humans is the regrowth of lost tissues or organs in response to injury. This is in contrast to wound healing, or partial regeneration, which involves closing up the injury site with some gradation of scar tissue. Some tissues such as skin, the vas deferens, and large organs including the liver can regrow quite readily, while others have been thought to have little or no capacity for regeneration following an injury.

<span class="mw-page-title-main">Melissa Little</span> Australian scientist and academic (born 1963)

Melissa Helen Little is an Australian scientist and academic who has served as director of Cell Biology at the Murdoch Children's Research Institute since 2019. She is also a Professor in the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and Program Leader of Stem Cells Australia. In January 2022, she became CEO of the Novo Nordisk Foundation Center for Stem Cell Medicine reNEW, an international stem cell research center based at University of Copenhagen, and a collaboration between the University of Copenhagen, Denmark, Murdoch Children’s Research Institute, Australia, and Leiden University Medical Center, The Netherlands.

<span class="mw-page-title-main">Air-liquid interface cell culture</span>

Air liquid interface cell culture (ALI) is a method of cell culture by which basal stem cells are grown with their basal surfaces in contact with media, and the top of the cellular layer is exposed to the air. The cells are then lifted and media is changed until the development of a mucociliary phenotype of a pseudostratified epithelium, similar to the tracheal epithelium.

<span class="mw-page-title-main">Sergiu P. Pașca</span> Romanian-American scientist and physician at Stanford University

Sergiu P. Pașca is a Romanian-American scientist and physician at Stanford University in California. He is renowned for his groundbreaking work creating and developing stem cell-based models of the human brain to gain insights into neuropsychiatric disease. His lab was the first to develop and name assembloids: multi-unit self-organizing structures created in 3D cultures that allow for the study of human neural circuit and systems functions in vitro. Pașca’s lab generated and published human cortico-striatal and cortico-motor assembloids in 2020. Combining regionalized neural organoids pioneered in the lab and studies with human forebrain assembloids and transplantation, in 2024, Pașca developed a therapeutic for a severe genetic disorder called Timothy Syndrome, which was published on the cover of Nature.

Cultrex Basement Membrane Extract (BME) is the trade name for a extracellular protein mixture secreted by Engelbreth-Holm-Swarm (EHS) mouse sarcoma cells and manufactured into a hydrogel by R&D Systems, a brand of Bio-Techne. Similar to Matrigel, this hydrogel is a natural extracellular matrix that mimics the complex extracellular environment within complex tissues. It is used as a general cell culture substrate across a wide variety of research applications.

<span class="mw-page-title-main">Experimental models of Alzheimer's disease</span>

Experimental models of Alzheimer's disease are organism or cellular models used in research to investigate biological questions about Alzheimer's disease as well as develop and test novel therapeutic treatments. Alzheimer's disease is a progressive neurodegenerative disorder associated with aging, which occurs both sporadically or due to familial passed mutations in genes associated with Alzheimer's pathology. Common symptoms associated with Alzheimer's disease include: memory loss, confusion, and mood changes.

Samira Musah is an American biomedical engineer and professor at the Duke University Pratt School of Engineering. She is known for her work in biomimetic systems, in particular for her work in developing an organ-on-a-chip model of the kidney glomerulus during her postdoctoral fellowship.

Intestines-on-a-chip are microfluidic bioengineered 3D-models of the real organ, which better mimic physiological features than conventional 3D intestinal organoid culture. A variety of different intestine-on-a-chip models systems have been developed and refined, all holding their individual strengths and weaknesses and collectively holding great promise to the ultimate goal of establishing these systems as reliable high-throughput platforms for drug testing and personalised medicine. The intestine is a highly complex organ system performing a diverse set of vital tasks, from nutrient digestion and absorption, hormone secretion, and immunological processes to neuronal activity, which makes it particularly challenging to model in vitro.

Meritxell Huch is a stem cell biologist and director at the Max Planck Institute of Molecular Cell Biology and Genetics. Her research considers tissue regeneration and the development of tissue-specific disease models for human organs. She was awarded a European Research Council Consolidator Grant in 2023.

A myelinoid or myelin organoid is a three dimensional in vitro cultured model derived from human pluripotent stem cells (hPSCs) that represents various brain regions, the spinal cord or the peripheral nervous system in early fetal human development. Myelinoids have the capacity to recapitulate aspects of brain developmental processes, microenvironments, cell to cell interaction, structural organization and cellular composition. The differentiating aspect dictating whether an organoid is deemed a cerebral organoid/brain organoid or myelinoid is the presence of myelination and compact myelin formation that is a defining feature of myelinoids. Due to the complex nature of the human brain, there is a need for model systems which can closely mimic complicated biological processes. Myelinoids provide a unique in vitro model through which myelin pathology, neurodegenerative diseases, developmental processes and therapeutic screening can be accomplished.

<span class="mw-page-title-main">Assembloid</span> Biological model of 2 or more cell types

An assembloid is an in vitro model that combines two or more organoids, spheroids, or cultured cell types to recapitulate structural and functional properties of an organ. They are typically derived from induced pluripotent stem cells. Assembloids have been used to study cell migration, neural circuit assembly, neuro-immune interactions, metastasis, and other complex tissue processes. The term "assembloid" was coined by Sergiu P. Pașca's lab in 2017.

References

  1. ↑ Zhao Z, Chen X, Dowbaj AM, Sljukic A, Bratlie K, Lin L, et al. (2022). "Organoids". Nature Reviews. Methods Primers. 2. doi:10.1038/s43586-022-00174-y. PMC   10270325 . PMID   37325195.
  2. ↑ Grens K (December 24, 2013). "2013's Big Advances in Science". The Scientist . Retrieved 26 December 2013.
  3. ↑ Mullard A (March 2023). "Mini-organs attract big pharma". Nature Reviews. Drug Discovery. 22 (3): 175–176. doi:10.1038/d41573-023-00030-y. PMID   36797431.
  4. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Lancaster MA, Knoblich JA (July 2014). "Organogenesis in a dish: modeling development and disease using organoid technologies". Science. 345 (6194): 1247125. doi:10.1126/science.1247125. PMID   25035496. S2CID   16105729.
  5. ↑ Wilson HV (June 1907). "A New Method by Which Sponges May Be Artificially Reared". Science. 25 (649): 912–915. Bibcode:1907Sci....25..912W. doi:10.1126/science.25.649.912. PMID   17842577.
  6. ↑ Holtfreter J (1944). "Experimental studies on the development of the pronephros". Rev. Can. Biol. 3: 220–250.
  7. ↑ Weiss P, Taylor AC (September 1960). "Reconstitution of Complete Organs From Single-Cell Suspensions of Chick Embryos in Advanced Stages of Differentiation". Proceedings of the National Academy of Sciences of the United States of America. 46 (9): 1177–1185. Bibcode:1960PNAS...46.1177W. doi: 10.1073/pnas.46.9.1177 . PMC   223021 . PMID   16590731.
  8. ↑ Rheinwald JG, Green H (November 1975). "Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma". Cell. 6 (3): 317–330. doi:10.1016/0092-8674(75)90183-x. PMID   1052770. S2CID   28185779.
  9. 1 2 Yi SA, Zhang Y, Rathnam C, Pongkulapa T, Lee KB (November 2021). "Bioengineering Approaches for the Advanced Organoid Research". Advanced Materials. 33 (45): e2007949. Bibcode:2021AdM....3307949Y. doi:10.1002/adma.202007949. PMC   8682947 . PMID   34561899.
  10. ↑ Li ML, Aggeler J, Farson DA, Hatier C, Hassell J, Bissell MJ (January 1987). "Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells". Proceedings of the National Academy of Sciences of the United States of America. 84 (1): 136–140. Bibcode:1987PNAS...84..136L. doi: 10.1073/pnas.84.1.136 . PMC   304157 . PMID   3467345.
  11. ↑ Barcellos-Hoff MH, Aggeler J, Ram TG, Bissell MJ (February 1989). "Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane". Development. 105 (2): 223–235. doi:10.1242/dev.105.2.223. PMC   2948482 . PMID   2806122.
  12. ↑ Streuli CH, Schmidhauser C, Bailey N, Yurchenco P, Skubitz AP, Roskelley C, et al. (May 1995). "Laminin mediates tissue-specific gene expression in mammary epithelia". The Journal of Cell Biology. 129 (3): 591–603. doi:10.1083/jcb.129.3.591. PMC   2120432 . PMID   7730398.
  13. ↑ Nahmias Y, Schwartz RE, Hu WS, Verfaillie CM, Odde DJ (June 2006). "Endothelium-mediated hepatocyte recruitment in the establishment of liver-like tissue in vitro". Tissue Engineering. 12 (6): 1627–1638. doi:10.1089/ten.2006.12.1627. PMID   16846358.
  14. ↑ Yong E (August 28, 2013). "Lab-Grown Model Brains". The Scientist . Retrieved 26 December 2013.
  15. 1 2 3 4 5 Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. (May 2009). "Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche". Nature. 459 (7244): 262–265. Bibcode:2009Natur.459..262S. doi:10.1038/nature07935. PMID   19329995. S2CID   4373784.
  16. 1 2 Unbekandt M, Davies JA (March 2010). "Dissociation of embryonic kidneys followed by reaggregation allows the formation of renal tissues". Kidney International. 77 (5): 407–416. doi: 10.1038/ki.2009.482 . PMID   20016472.
  17. ↑ Peng H, Poovaiah N, Forrester M, Cochran E, Wang Q (December 2014). "Ex Vivo Culture of Primary Intestinal Stem Cells in Collagen Gels and Foams". ACS Biomaterials Science & Engineering. 1 (1): 37–42. doi:10.1021/ab500041d. PMID   33435081.
  18. ↑ Peng H, Wang C, Xu X, Yu C, Wang Q (January 2015). "An intestinal Trojan horse for gene delivery". Nanoscale. 7 (10): 4354–4360. doi:10.1039/c4nr06377e. PMID   25619169.
  19. ↑ Lawrence ML, Chang CH, Davies JA (March 2015). "Transport of organic anions and cations in murine embryonic kidney development and in serially-reaggregated engineered kidneys". Scientific Reports. 5: 9092. Bibcode:2015NatSR...5.9092L. doi:10.1038/srep09092. PMC   4357899 . PMID   25766625.
  20. ↑ Xinaris C, Benedetti V, Rizzo P, Abbate M, Corna D, Azzollini N, et al. (November 2012). "In vivo maturation of functional renal organoids formed from embryonic cell suspensions". Journal of the American Society of Nephrology. 23 (11): 1857–1868. doi:10.1681/ASN.2012050505. PMC   3482737 . PMID   23085631.
  21. ↑ Yui S, Nakamura T, Sato T, Nemoto Y, Mizutani T, Zheng X, et al. (March 2012). "Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5⁺ stem cell". Nature Medicine. 18 (4): 618–623. doi:10.1038/nm.2695. PMID   22406745.
  22. 1 2 3 Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, et al. (September 2013). "Cerebral organoids model human brain development and microcephaly". Nature. 501 (7467): 373–379. Bibcode:2013Natur.501..373L. doi:10.1038/nature12517. PMC   3817409 . PMID   23995685.
  23. ↑ Huch M, Dorrell C, Boj SF, van Es JH, Li VS, van de Wetering M, et al. (February 2013). "In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration". Nature. 494 (7436): 247–250. doi:10.1038/nature11826. PMC   3634804 . PMID   23354049.
  24. ↑ Shkumatov A, Baek K, Kong H (April 2014). "Matrix rigidity-modulated cardiovascular organoid formation from embryoid bodies". PLOS ONE. 9 (4): e94764. Bibcode:2014PLoSO...994764S. doi: 10.1371/journal.pone.0094764 . PMC   3986240 . PMID   24732893.
  25. ↑ Murry CE, Keller G (February 2008). "Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development". Cell. 132 (4): 661–680. doi: 10.1016/j.cell.2008.02.008 . PMID   18295582.
  26. ↑ Choudhury D, Ashok A, Naing MW (March 2020). "Commercialization of Organoids". Trends in Molecular Medicine. 26 (3): 245–249. doi:10.1016/j.molmed.2019.12.002. PMID   31982341. S2CID   210922708.
  27. ↑ Li ML, Aggeler J, Farson DA, Hatier C, Hassell J, Bissell MJ (January 1987). "Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells". Proceedings of the National Academy of Sciences of the United States of America. 84 (1): 136–140. Bibcode:1987PNAS...84..136L. doi: 10.1073/pnas.84.1.136 . PMC   304157 . PMID   3467345.
  28. 1 2 3 Pastuła A, Middelhoff M, Brandtner A, Tobiasch M, Höhl B, Nuber AH, et al. (2016). "Three-Dimensional Gastrointestinal Organoid Culture in Combination with Nerves or Fibroblasts: A Method to Characterize the Gastrointestinal Stem Cell Niche". Stem Cells International. 2016: 3710836. doi: 10.1155/2016/3710836 . PMC   4677245 . PMID   26697073.
  29. ↑ Takahashi K, Yamanaka S (August 2006). "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors". Cell. 126 (4): 663–676. doi:10.1016/j.cell.2006.07.024. hdl: 2433/159777 . PMID   16904174.
  30. ↑ Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (November 2013). "Genome engineering using the CRISPR-Cas9 system". Nature Protocols. 8 (11): 2281–2308. doi:10.1038/nprot.2013.143. PMC   3969860 . PMID   24157548.
  31. ↑ Lavazza A, Massimini M (September 2018). "Cerebral organoids: ethical issues and consciousness assessment". Journal of Medical Ethics. 44 (9): 606–610. doi: 10.1136/medethics-2017-104555 . PMID   29491041.
  32. ↑ Scully RP (6 July 2019). "Miniature brains grown in the lab have human-like neural activity". New Scientist . No. 3237.
  33. ↑ Sample I (21 October 2019). "Scientists 'may have crossed ethical line' in growing human brains". The Guardian . p. 15.
  34. ↑ Cai H, Ao Z, Tian C, et al. (2023). "Brain organoid reservoir computing for artificial intelligence". Nat Electron. 6 (12): 1032–1039. doi:10.1038/s41928-023-01069-w.
  35. ↑ Smirnova L, Caffo BS, Gracias DH, Huang Q, Morales Pantoja IE, Tang B, et al. (2023). "Organoid intelligence (OI): the new frontier in biocomputing and intelligence-in-a-dish". Front Sci. 1: 1017235. doi: 10.3389/fsci.2023.1017235 .
  36. ↑ Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, et al. (November 2011). "Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium". Gastroenterology. 141 (5): 1762–1772. doi: 10.1053/j.gastro.2011.07.050 . PMID   21889923.
  37. ↑ Jung P, Sato T, Merlos-Suárez A, Barriga FM, Iglesias M, Rossell D, et al. (September 2011). "Isolation and in vitro expansion of human colonic stem cells". Nature Medicine. 17 (10): 1225–1227. doi:10.1038/nm.2470. PMID   21892181. S2CID   205388154.
  38. ↑ Cai T, Qi Y, Jergens A, Wannemuehler M, Barrett TA, Wang Q (2018). "Effects of six common dietary nutrients on murine intestinal organoid growth". PLOS ONE. 13 (2): e0191517. doi: 10.1371/journal.pone.0191517 . PMC   5794098 . PMID   29389993.
  39. ↑ Qi Y, Lohman J, Bratlie KM, Peroutka-Bigus N, Bellaire B, Wannemuehler M, et al. (September 2019). "Vitamin C and B3 as new biomaterials to alter intestinal stem cells". Journal of Biomedical Materials Research. Part A. 107 (9): 1886–1897. doi:10.1002/jbm.a.36715. PMC   6626554 . PMID   31071241.
  40. ↑ Davoudi Z, Peroutka-Bigus N, Bellaire B, Wannemuehler M, Barrett TA, Narasimhan B, et al. (April 2018). "Intestinal organoids containing poly(lactic-co-glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases". Journal of Biomedical Materials Research. Part A. 106 (4): 876–886. doi:10.1002/jbm.a.36305. PMC   5826879 . PMID   29226615.
  41. ↑ Davoudi Z, Peroutka-Bigus N, Bellaire B, Jergens A, Wannemuehler M, Wang Q (May 2021). "Gut Organoid as a New Platform to Study Alginate and Chitosan Mediated PLGA Nanoparticles for Drug Delivery". Marine Drugs. 19 (5): 282. doi: 10.3390/md19050282 . PMC   8161322 . PMID   34065505.
  42. ↑ Qi Y, Shi E, Peroutka-Bigus N, Bellaire B, Wannemuehler M, Jergens A, et al. (May 2018). "Ex Vivo Study of Telluride Nanowires in Minigut". Journal of Biomedical Nanotechnology. 14 (5): 978–986. doi:10.1166/jbn.2018.2578. PMID   29883567.
  43. ↑ Reding B, Carter P, Qi Y, Li Z, Wu Y, Wannemuehler M, et al. (April 2021). "Manipulate intestinal organoids with niobium carbide nanosheets". Journal of Biomedical Materials Research. Part A. 109 (4): 479–487. doi:10.1002/jbm.a.37032. PMID   32506610.
  44. ↑ Zietek T, Giesbertz P, Ewers M, Reichart F, Weinmüller M, Urbauer E, et al. (2020). "Organoids to Study Intestinal Nutrient Transport, Drug Uptake and Metabolism - Update to the Human Model and Expansion of Applications". Frontiers in Bioengineering and Biotechnology. 8: 577656. doi: 10.3389/fbioe.2020.577656 . PMC   7516017 . PMID   33015026.
  45. ↑ Zietek T, Rath E, Haller D, Daniel H (November 2015). "Intestinal organoids for assessing nutrient transport, sensing and incretin secretion". Scientific Reports. 5 (1): 16831. Bibcode:2015NatSR...516831Z. doi: 10.1038/srep16831 . PMC   4652176 . PMID   26582215.
  46. ↑ Rahmani S, Breyner NM, Su HM, Verdu EF, Didar TF (February 2019). "Intestinal organoids: A new paradigm for engineering intestinal epithelium in vitro". Biomaterials. 194: 195–214. doi:10.1016/j.biomaterials.2018.12.006. PMID   30612006. S2CID   58603850.
  47. ↑ Sun L, Rollins D, Qi Y, Fredericks J, Mansell TJ, Jergens A, et al. (December 2020). "TNFα regulates intestinal organoids from mice with both defined and conventional microbiota". International Journal of Biological Macromolecules. 164: 548–556. doi:10.1016/j.ijbiomac.2020.07.176. PMC   7657954 . PMID   32693143.
  48. ↑ Tong T, Qi Y, Rollins D, Bussiere LD, Dhar D, Miller CL, et al. (December 2023). "Rational design of oral drugs targeting mucosa delivery with gut organoid platforms". Bioactive Materials. 30: 116–128. doi:10.1016/j.bioactmat.2023.07.014. PMC   10406959 . PMID   37560199.
  49. ↑ Davoudi Z, Atherly T, Borcherding DC, Jergens AE, Wannemuehler M, Barrett TA, et al. (December 2023). "Study Transportation of Drugs within Newly Established Murine Colon Organoid Systems". Advanced Biology. 7 (12): e2300103. doi:10.1002/adbi.202300103. PMC   10840714 . PMID   37607116.
  50. ↑ Sakib S, Zou S (February 2024). "Attenuation of Chronic Inflammation in Intestinal Organoids with Graphene Oxide-Mediated Tumor Necrosis Factor-α_Small Interfering RNA Delivery". Langmuir. 40 (7): 3402–3413. doi:10.1021/acs.langmuir.3c02741. PMC   10883062 . PMID   38325360.
  51. ↑ Lindemans C, Mertelsmann A, Dudakov JA, Velardi E, Hua G, O'Connor M, et al. (2014). "IL-22 Administration Protects Intestinal Stem Cells from Gvhd". Biology of Blood and Marrow Transplantation. 20 (2): S53–S54. doi: 10.1016/j.bbmt.2013.12.056 .
  52. ↑ Zhang YG, Wu S, Xia Y, Sun J (September 2014). "Salmonella-infected crypt-derived intestinal organoid culture system for host-bacterial interactions". Physiological Reports. 2 (9): e12147. doi:10.14814/phy2.12147. PMC   4270227 . PMID   25214524.
  53. ↑ Geiser P, Di Martino ML, Samperio Ventayol P, Eriksson J, Sima E, Al-Saffar AK, et al. (January 2021). Sperandio V (ed.). "Salmonella enterica Serovar Typhimurium Exploits Cycling through Epithelial Cells To Colonize Human and Murine Enteroids". mBio. 12 (1). doi:10.1128/mBio.02684-20. PMC   7844539 . PMID   33436434.
  54. ↑ Dutta D, Heo I, O'Connor R (September 2019). "Studying Cryptosporidium Infection in 3D Tissue-derived Human Organoid Culture Systems by Microinjection". Journal of Visualized Experiments (151): 59610. doi:10.3791/59610. PMID   31566619. S2CID   203377662.
  55. ↑ Co JY, Margalef-Català M, Li X, Mah AT, Kuo CJ, Monack DM, et al. (February 2019). "Controlling Epithelial Polarity: A Human Enteroid Model for Host-Pathogen Interactions". Cell Reports. 26 (9): 2509–2520.e4. doi:10.1016/j.celrep.2019.01.108. PMC   6391775 . PMID   30811997.
  56. ↑ Tong T, Qi Y, Bussiere LD, Wannemuehler M, Miller CL, Wang Q, et al. (August 2020). "Transport of artificial virus-like nanocarriers through intestinal monolayers via microfold cells". Nanoscale. 12 (30): 16339–16347. doi: 10.1039/d0nr03680c . PMID   32725029.
  57. 1 2 Noel G, Baetz NW, Staab JF, Donowitz M, Kovbasnjuk O, Pasetti MF, et al. (March 2017). "A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions". Scientific Reports. 7 (1): 45270. Bibcode:2017NatSR...745270N. doi:10.1038/srep45270. PMC   5366908 . PMID   28345602.
  58. ↑ Bouchi R, Foo KS, Hua H, Tsuchiya K, Ohmura Y, Sandoval PR, et al. (June 2014). "FOXO1 inhibition yields functional insulin-producing cells in human gut organoid cultures". Nature Communications. 5: 4242. Bibcode:2014NatCo...5.4242B. doi:10.1038/ncomms5242. PMC   4083475 . PMID   24979718.
  59. ↑ Sontheimer-Phelps A, Chou DB, Tovaglieri A, Ferrante TC, Duckworth T, Fadel C, et al. (2020). "Human Colon-on-a-Chip Enables Continuous In Vitro Analysis of Colon Mucus Layer Accumulation and Physiology". Cellular and Molecular Gastroenterology and Hepatology. 9 (3): 507–526. doi:10.1016/j.jcmgh.2019.11.008. PMC   7036549 . PMID   31778828.
  60. ↑ Grassart A, Malardé V, Gobaa S, Sartori-Rupp A, Kerns J, Karalis K, et al. (September 2019). "Bioengineered Human Organ-on-Chip Reveals Intestinal Microenvironment and Mechanical Forces Impacting Shigella Infection". Cell Host & Microbe. 26 (3): 435–444.e4. doi: 10.1016/j.chom.2019.08.007 . PMID   31492657. S2CID   201868491.
  61. 1 2 3 McCracken KW, Catá EM, Crawford CM, Sinagoga KL, Schumacher M, Rockich BE, et al. (December 2014). "Modelling human development and disease in pluripotent stem-cell-derived gastric organoids". Nature. 516 (7531): 400–404. Bibcode:2014Natur.516..400M. doi:10.1038/nature13863. PMC   4270898 . PMID   25363776.
  62. ↑ Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, et al. (January 2010). "Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro". Cell Stem Cell. 6 (1): 25–36. doi: 10.1016/j.stem.2009.11.013 . PMID   20085740.
  63. ↑ Li X, Nadauld L, Ootani A, Corney DC, Pai RK, Gevaert O, et al. (July 2014). "Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture". Nature Medicine. 20 (7): 769–777. doi:10.1038/nm.3585. PMC   4087144 . PMID   24859528.
  64. 1 2 Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, Hopmans ES, et al. (August 2014). "Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer". Genome Biology. 15 (8): 428. doi: 10.1186/s13059-014-0428-9 . PMC   4145231 . PMID   25315765.
  65. 1 2 Hisha H, Tanaka T, Kanno S, Tokuyama Y, Komai Y, Ohe S, et al. (November 2013). "Establishment of a novel lingual organoid culture system: generation of organoids having mature keratinized epithelium from adult epithelial stem cells". Scientific Reports. 3: 3224. Bibcode:2013NatSR...3.3224H. doi:10.1038/srep03224. PMC   3828633 . PMID   24232854.
  66. 1 2 Aihara E, Mahe MM, Schumacher MA, Matthis AL, Feng R, Ren W, et al. (November 2015). "Characterization of stem/progenitor cell cycle using murine circumvallate papilla taste bud organoid". Scientific Reports. 5: 17185. Bibcode:2015NatSR...517185A. doi:10.1038/srep17185. PMC   4665766 . PMID   26597788.
  67. ↑ Ren W, Lewandowski BC, Watson J, Aihara E, Iwatsuki K, Bachmanov AA, et al. (November 2014). "Single Lgr5- or Lgr6-expressing taste stem/progenitor cells generate taste bud cells ex vivo". Proceedings of the National Academy of Sciences of the United States of America. 111 (46): 16401–16406. Bibcode:2014PNAS..11116401R. doi: 10.1073/pnas.1409064111 . PMC   4246268 . PMID   25368147.
  68. ↑ Hermans F, Hasevoets S, Vankelecom H, Bronckaers A, Lambrichts I (March 2024). "From Pluripotent Stem Cells to Organoids and Bioprinting: Recent Advances in Dental Epithelium and Ameloblast Models to Study Tooth Biology and Regeneration". Stem Cell Reviews and Reports. 20 (5): 1184–1199. doi: 10.1007/s12015-024-10702-w . PMC   11222197 . PMID   38498295.
  69. ↑ Martin A, Barbesino G, Davies TF (1999). "T-cell receptors and autoimmune thyroid disease--signposts for T-cell-antigen driven diseases". International Reviews of Immunology. 18 (1–2): 111–140. doi:10.3109/08830189909043021. PMID   10614741.
  70. ↑ Bredenkamp N, Ulyanchenko S, O'Neill KE, Manley NR, Vaidya HJ, Blackburn CC (September 2014). "An organized and functional thymus generated from FOXN1-reprogrammed fibroblasts". Nature Cell Biology. 16 (9): 902–908. doi:10.1038/ncb3023. PMC   4153409 . PMID   25150981.
  71. 1 2 3 Vianello F, Poznansky MC (2007). "Generation of a tissue-engineered thymic organoid". Immunological Tolerance. Methods in Molecular Biology. Vol. 380. pp. 163–70. doi:10.1007/978-1-59745-395-0_9. ISBN   978-1-59745-395-0. PMID   17876092.
  72. ↑ Sakib S, Uchida A, Valenzuela-Leon P, Yu Y, Valli-Pulaski H, Orwig K, et al. (June 2019). "Formation of organotypic testicular organoids in microwell culture†". Biology of Reproduction. 100 (6): 1648–1660. doi:10.1093/biolre/ioz053. PMC   7302515 . PMID   30927418.
  73. ↑ Drost J, Karthaus WR, Gao D, Driehuis E, Sawyers CL, Chen Y, et al. (February 2016). "Organoid culture systems for prostate epithelial and cancer tissue". Nature Protocols. 11 (2): 347–358. doi:10.1038/nprot.2016.006. PMC   4793718 . PMID   26797458.
  74. ↑ Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen MM, et al. (January 2015). "Long-term culture of genome-stable bipotent stem cells from adult human liver". Cell. 160 (1–2): 299–312. doi:10.1016/j.cell.2014.11.050. PMC   4313365 . PMID   25533785.
  75. ↑ Li P, Li Y, Wang Y, Liu J, Lavrijsen M, Li Y, et al. (January 2022). "Recapitulating hepatitis E virus-host interactions and facilitating antiviral drug discovery in human liver-derived organoids". Science Advances. 8 (3): eabj5908. Bibcode:2022SciA....8.5908L. doi:10.1126/sciadv.abj5908. hdl: 11250/3047921 . PMC   8769558 . PMID   35044825. S2CID   246069868.
  76. ↑ Huch M, Bonfanti P, Boj SF, Sato T, Loomans CJ, van de Wetering M, et al. (October 2013). "Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis". The EMBO Journal. 32 (20): 2708–2721. doi:10.1038/emboj.2013.204. PMC   3801438 . PMID   24045232.
  77. ↑ Hou S, Tiriac H, Sridharan BP, Scampavia L, Madoux F, Seldin J, et al. (July 2018). "Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening". SLAS Discovery. 23 (6): 574–584. doi:10.1177/2472555218766842. PMC   6013403 . PMID   29673279.
  78. ↑ Wolff RA, Wang-Gillam A, Alvarez H, Tiriac H, Engle D, Hou S, et al. (March 2018). "Dynamic changes during the treatment of pancreatic cancer". Oncotarget. 9 (19): 14764–14790. doi:10.18632/oncotarget.24483. PMC   5871077 . PMID   29599906.
  79. ↑ Below CR, Kelly J, Brown A, Humphries JD, Hutton C, Xu J, et al. (January 2022). "A microenvironment-inspired synthetic three-dimensional model for pancreatic ductal adenocarcinoma organoids". Nature Materials. 21 (1): 110–119. doi:10.1038/s41563-021-01085-1. PMC   7612137 . PMID   34518665.
  80. ↑ Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. (October 2007). "Identification of stem cells in small intestine and colon by marker gene Lgr5". Nature. 449 (7165): 1003–1007. Bibcode:2007Natur.449.1003B. doi:10.1038/nature06196. PMID   17934449. S2CID   4349637.
  81. ↑ Lee JH, Bhang DH, Beede A, Huang TL, Stripp BR, Bloch KD, et al. (January 2014). "Lung stem cell differentiation in mice directed by endothelial cells via a BMP4-NFATc1-thrombospondin-1 axis". Cell. 156 (3): 440–455. doi:10.1016/j.cell.2013.12.039. PMC   3951122 . PMID   24485453.
  82. ↑ Takasato M, Er PX, Chiu HS, Maier B, Baillie GJ, Ferguson C, et al. (October 2015). "Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis". Nature. 526 (7574): 564–568. Bibcode:2015Natur.526..564T. doi:10.1038/nature15695. PMID   26444236. S2CID   4443766.
  83. 1 2 3 Freedman BS, Brooks CR, Lam AQ, Fu H, Morizane R, Agrawal V, et al. (October 2015). "Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids". Nature Communications. 6: 8715. Bibcode:2015NatCo...6.8715F. doi:10.1038/ncomms9715. PMC   4620584 . PMID   26493500.
  84. ↑ Morizane R, Lam AQ, Freedman BS, Kishi S, Valerius MT, Bonventre JV (November 2015). "Nephron organoids derived from human pluripotent stem cells model kidney development and injury". Nature Biotechnology. 33 (11): 1193–1200. doi:10.1038/nbt.3392. PMC   4747858 . PMID   26458176.
  85. ↑ van den Brink SC, Baillie-Johnson P, Balayo T, Hadjantonakis AK, Nowotschin S, Turner DA, et al. (November 2014). "Symmetry breaking, germ layer specification and axial organisation in aggregates of mouse embryonic stem cells". Development. 141 (22): 4231–4242. doi:10.1242/dev.113001. PMC   4302915 . PMID   25371360.
  86. ↑ Turner DA, Baillie-Johnson P, Martinez Arias A (February 2016). "Organoids and the genetically encoded self-assembly of embryonic stem cells". BioEssays. 38 (2): 181–191. doi:10.1002/bies.201500111. PMC   4737349 . PMID   26666846.
  87. ↑ Turner DA, Girgin M, Alonso-Crisostomo L, Trivedi V, Baillie-Johnson P, Glodowski CR, et al. (November 2017). "Anteroposterior polarity and elongation in the absence of extra-embryonic tissues and of spatially localised signalling in gastruloids: mammalian embryonic organoids". Development. 144 (21): 3894–3906. doi:10.1242/dev.150391. PMC   5702072 . PMID   28951435.
  88. 1 2 Beccari L, Moris N, Girgin M, Turner DA, Baillie-Johnson P, Cossy AC, et al. (October 2018). "Multi-axial self-organization properties of mouse embryonic stem cells into gastruloids". Nature. 562 (7726): 272–276. Bibcode:2018Natur.562..272B. doi:10.1038/s41586-018-0578-0. PMID   30283134. S2CID   52915553.
  89. ↑ Rivron N (27 June 2018). "Blastoid: The backstory of the formation of blastocyst-like structure solely from stem cells". The Node. The Company of Biologists Ltd.
  90. ↑ "Blastoid". Nicolas Rivron Lab. Netherlands.
  91. ↑ Rivron NC, Frias-Aldeguer J, Vrij EJ, Boisset JC, Korving J, Vivié J, et al. (May 2018). "Blastocyst-like structures generated solely from stem cells". Nature. 557 (7703): 106–111. Bibcode:2018Natur.557..106R. doi:10.1038/s41586-018-0051-0. PMID   29720634. S2CID   13749109.
  92. ↑ Rawlings TM, Makwana K, Tryfonos M, Lucas ES (July 2021). "Organoids to model the endometrium: implantation and beyond". Reproduction & Fertility. 2 (3): R85–R101. doi:10.1530/RAF-21-0023. PMC   8801025 . PMID   35118399.
  93. ↑ Lee EJ, Kim DE, Azeloglu EU, Costa KD (February 2008). "Engineered cardiac organoid chambers: toward a functional biological model ventricle". Tissue Engineering. Part A. 14 (2): 215–225. doi:10.1089/tea.2007.0351. PMID   18333774.
  94. ↑ Molteni M (2018-06-27). "These Beating Mini-Hearts Could Save Big Bucks—And Maybe Lives". WIRED. Retrieved 2018-06-30.
  95. ↑ Wiley LA, Burnight ER, DeLuca AP, Anfinson KR, Cranston CM, Kaalberg EE, et al. (July 2016). "cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness". Scientific Reports. 6: 30742. Bibcode:2016NatSR...630742W. doi:10.1038/srep30742. PMC   4965859 . PMID   27471043.
  96. ↑ Zilova L, Weinhardt V, Tavhelidse T, Schlagheck C, Thumberger T, Wittbrodt J (July 2021). Arias AM, Stainier DY (eds.). "Fish primary embryonic pluripotent cells assemble into retinal tissue mirroring in vivo early eye development". eLife. 10: e66998. doi: 10.7554/eLife.66998 . PMC   8275126 . PMID   34252023.
  97. ↑ Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, et al. (January 2018). "A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity". Cell. 172 (1–2): 373–386.e10. doi: 10.1016/j.cell.2017.11.010 . PMID   29224780.
  98. ↑ van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, et al. (May 2015). "Prospective derivation of a living organoid biobank of colorectal cancer patients". Cell. 161 (4): 933–945. doi:10.1016/j.cell.2015.03.053. PMC   6428276 . PMID   25957691.
  99. ↑ Quereda V, Hou S, Madoux F, Scampavia L, Spicer TP, Duckett D (September 2018). "A Cytotoxic Three-Dimensional-Spheroid, High-Throughput Assay Using Patient-Derived Glioma Stem Cells". SLAS Discovery. 23 (8): 842–849. doi:10.1177/2472555218775055. PMC   6102052 . PMID   29750582.
  100. ↑ Dayton TL, Alcala N, Moonen L, den Hartigh L, Geurts V, Mangiante L, et al. (December 2023). "Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites". Cancer Cell. 41 (12): 2083–2099.e9. doi: 10.1016/j.ccell.2023.11.007 . PMID   38086335.
  101. ↑ Zidarič T, Gradišnik L, Velnar T (September 2022). "Astrocytes and human artificial blood-brain barrier models". Bosnian Journal of Basic Medical Sciences. 22 (5): 651–672. doi:10.17305/bjbms.2021.6943. PMC   9519155 . PMID   35366791.
  102. ↑ Zietek T, Rath E, Haller D, Daniel H (November 2015). "Intestinal organoids for assessing nutrient transport, sensing and incretin secretion". Scientific Reports. 5: 16831. Bibcode:2015NatSR...516831Z. doi:10.1038/srep16831. PMC   4652176 . PMID   26582215.
  103. 1 2 3 Cruz NM, Song X, Czerniecki SM, Gulieva RE, Churchill AJ, Kim YK, et al. (November 2017). "Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease". Nature Materials. 16 (11): 1112–1119. Bibcode:2017NatMa..16.1112C. doi:10.1038/nmat4994. PMC   5936694 . PMID   28967916.
  104. 1 2 3 Kim YK, Refaeli I, Brooks CR, Jing P, Gulieva RE, Hughes MR, et al. (December 2017). "Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development". Stem Cells. 35 (12): 2366–2378. doi:10.1002/stem.2707. PMC   5742857 . PMID   28905451.
  105. ↑ Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. (November 2007). "Induction of pluripotent stem cells from adult human fibroblasts by defined factors". Cell. 131 (5): 861–872. doi:10.1016/j.cell.2007.11.019. hdl: 2433/49782 . PMID   18035408. S2CID   8531539.
  106. 1 2 3 Hsieh WC, Ramadesikan S, Fekete D, Aguilar RC (2018-02-14). "Kidney-differentiated cells derived from Lowe Syndrome patient's iPSCs show ciliogenesis defects and Six2 retention at the Golgi complex". PLOS ONE. 13 (2): e0192635. Bibcode:2018PLoSO..1392635H. doi: 10.1371/journal.pone.0192635 . PMC   5812626 . PMID   29444177.
  107. ↑ Howden SE, Thomson JA, Little MH (May 2018). "Simultaneous reprogramming and gene editing of human fibroblasts". Nature Protocols. 13 (5): 875–898. doi:10.1038/nprot.2018.007. PMC   5997775 . PMID   29622803.
  108. 1 2 3 4 Forbes TA, Howden SE, Lawlor K, Phipson B, Maksimovic J, Hale L, et al. (May 2018). "Patient-iPSC-Derived Kidney Organoids Show Functional Validation of a Ciliopathic Renal Phenotype and Reveal Underlying Pathogenetic Mechanisms". American Journal of Human Genetics. 102 (5): 816–831. doi:10.1016/j.ajhg.2018.03.014. PMC   5986969 . PMID   29706353.
  109. 1 2 Tanigawa S, Islam M, Sharmin S, Naganuma H, Yoshimura Y, Haque F, et al. (September 2018). "Organoids from Nephrotic Disease-Derived iPSCs Identify Impaired NEPHRIN Localization and Slit Diaphragm Formation in Kidney Podocytes". Stem Cell Reports. 11 (3): 727–740. doi:10.1016/j.stemcr.2018.08.003. PMC   6135868 . PMID   30174315.
  110. ↑ Engle SJ, Blaha L, Kleiman RJ (November 2018). "Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons". Neuron. 100 (4): 783–797. doi: 10.1016/j.neuron.2018.10.033 . PMID   30465765.
  111. ↑ Rath E, Chamaillard M (eds.). "Metabolites". Special Issue of the Metabolites Journal. Retrieved 2022-10-16.
  112. 1 2 Dekkers JF, Wiegerinck CL, de Jonge HR, Bronsveld I, Janssens HM, de Winter-de Groot KM, et al. (July 2013). "A functional CFTR assay using primary cystic fibrosis intestinal organoids". Nature Medicine. 19 (7): 939–945. doi:10.1038/nm.3201. PMID   23727931. S2CID   5369669.
  113. 1 2 Dekkers JF, Berkers G, Kruisselbrink E, Vonk A, de Jonge HR, Janssens HM, et al. (June 2016). "Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis". Science Translational Medicine. 8 (344): 344ra84. doi:10.1126/scitranslmed.aad8278. PMID   27334259. S2CID   19462535.
  114. ↑ Schwank G, Koo BK, Sasselli V, Dekkers JF, Heo I, Demircan T, et al. (December 2013). "Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients". Cell Stem Cell. 13 (6): 653–658. doi: 10.1016/j.stem.2013.11.002 . PMID   24315439.
  115. ↑ Zhang FL, Hu Z, Wang YF, Zhang WJ, Zhou BW, Sun QS, et al. (October 2023). "Organoids transplantation attenuates intestinal ischemia/reperfusion injury in mice through L-Malic acid-mediated M2 macrophage polarization". Nature Communications. 14 (1): 6779. doi:10.1038/s41467-023-42502-0. PMC   10600233 . PMID   37880227.
  116. ↑ "World's first mini organ transportation to a patient with ulcerative colitis". Tokyo Medical and Dental University via medicalxpress.com. Retrieved 18 September 2022.
  117. ↑ Watanabe S, Kobayashi S, Ogasawara N, Okamoto R, Nakamura T, Watanabe M, et al. (March 2022). "Transplantation of intestinal organoids into a mouse model of colitis". Nature Protocols. 17 (3): 649–671. doi:10.1038/s41596-021-00658-3. PMID   35110738. S2CID   246488596.
  118. 1 2 3 4 5 Ader M, Tanaka EM (December 2014). "Modeling human development in 3D culture". Current Opinion in Cell Biology. 31: 23–28. doi:10.1016/j.ceb.2014.06.013. PMID   25033469.
  119. ↑ Martinez-Morales JR, Cavodeassi F, Bovolenta P (2017). "Coordinated Morphogenetic Mechanisms Shape the Vertebrate Eye". Frontiers in Neuroscience. 11: 721. doi: 10.3389/fnins.2017.00721 . PMC   5742352 . PMID   29326547.
  120. ↑ Gordon A, Yoon SJ, Tran SS, Makinson CD, Park JY, Andersen J, et al. (March 2021). "Long-term maturation of human cortical organoids matches key early postnatal transitions". Nature Neuroscience. 24 (3): 331–342. doi:10.1038/s41593-021-00802-y. PMC   8109149 . PMID   33619405.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.